Evidence map›Paper›PMID 42651078›Full record

ArticleDiagnostics (Basel, Switzerland)2026

Occult Esophageal Squamous Cell Carcinoma Presenting as Bone-Predominant Carcinoma of Unknown Primary: A Case Report of a p40-Negative Vertebral Metastasis.

Hassan Brim, Wardah Bajwa, Anas Brim, Farshad Aduli, Amro AbdelLatief, Rabia Zafar, Adeyinka O Laiyemo, Hassan Ashktorab

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hassan BrimDepartment of Medicine, GI Division, Cancer Center, Howard University Hospital, Washington, DC 20060, USA.
Wardah BajwaDepartment of Medicine, GI Division, Cancer Center, Howard University Hospital, Washington, DC 20060, USA.
Anas BrimDepartment of Medicine, GI Division, Cancer Center, Howard University Hospital, Washington, DC 20060, USA.
Farshad AduliDepartment of Medicine, GI Division, Cancer Center, Howard University Hospital, Washington, DC 20060, USA.
Amro AbdelLatiefDepartment of Medicine, GI Division, Cancer Center, Howard University Hospital, Washington, DC 20060, USA.
Rabia ZafarDepartment of Medicine, GI Division, Cancer Center, Howard University Hospital, Washington, DC 20060, USA.
Adeyinka O LaiyemoDepartment of Medicine, GI Division, Cancer Center, Howard University Hospital, Washington, DC 20060, USA.
Hassan AshktorabDepartment of Medicine, GI Division, Cancer Center, Howard University Hospital, Washington, DC 20060, USA.ORCID 0000-0002-4048-4666

Funding

Inactivation of MSH3 in Colorectal Cancer and RaceR01CA258519 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ASHKTORAB, HASSAN, CARETHERS, JOHN M · 2021 to 2025
$2.9M
NCI NIH HHS R01 CA258519NCI NIH HHS R01CA258519
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bone biopsybone metastasiscarcinoma of unknown primarydiagnostic pitfallsesophageal squamous cell carcinomaimmunohistochemistryp40-negative staining

Identifiers

PMID42651078
PMCPMC13512739

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.